Clinical Trial Update: A Study of Metabolic Agents Following Brain Radiation

View source ↗

Summary

Completed clinical trial evaluating metabolic agents following brain radiation for central nervous system neoplasms. The snippet provides no results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Neoplasms

Snippet

Sponsor: Mayo Clinic | Conditions: CNS Malignancy | Status: COMPLETED